Prospective Phase I/II Study of Adjuvant Radiochemotherapy for Gastric Cancer
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Phase I and II: Acute toxicity: assessed according to National Cancer Institute of Canada (NCIC) and Radiation Therapy Oncology Group (RTOG) toxicity assessment criteria.
10 years
No
Jolie Ringash, MD
Principal Investigator
Princess Margaret Hospital, Canada
Canada: Review Ethics Committee
UHN REB 02-0134-C
NCT00188266
August 2002
August 2016
Name | Location |
---|